Medicine
Famotidine and Ibuprofen 26.6 mg/800 mg tablet
Famotidine and Ibuprofen 26.6 mg/800 mg tablet is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68ºF to 77°F), excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Famotidine and Ibuprofen
- Brand
- Sold under the generic name
- Strength
- 26.6 mg/800 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 6 blister pack and 46 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaAdvanced Rx of TennesseePhoenix RXAdvanced Rx Pharmacy of TennesseeAscent PharmaceuticalsDoc Rx16 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68ºF to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 August 2021
- Identifiers
- RxCUI 1100066DailyMed set ID 66524c84-35bc-4e7f-897a-f63fa4bca432, 4ee3e849-2197-8883-e063-6394a90a1748, 21688404-41fb-487e-8ba0-aea4431a42fa +18NDC 72578-214, 85509-1626, 59651-908 +18Application ANDA218684, ANDA211890, ANDA219538 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 16 labelers. The register lists 49 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 67877-626-01 | Ascend LaboratoriesIndia | 4 August 2021 |
| 500 tablet, film coated in 1 bottle | 67877-626-05 | Ascend LaboratoriesIndia | 4 August 2021 |
| 6 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 67877-626-06 | Ascend LaboratoriesIndia | 4 August 2021 |
| 90 tablet, film coated in 1 bottle | 67877-626-90 | Ascend LaboratoriesIndia | 4 August 2021 |
| 90 tablet, film coated in 1 bottle | 59651-908-90 | Aurobindo PharmaIndia | 30 June 2025 |
| 90 tablet in 1 bottle | 31722-315-90 | Camber PharmaceuticalsIndia | 15 March 2023 |
| 90 tablet in 1 bottle | 72578-214-16 | Viona PharmaceuticalsIndia | 1 June 2025 |
| 90 tablet in 1 bottle | 70771-1924-9 | Zydus LifesciencesIndia | 1 June 2025 |
| 500 tablet in 1 bottle | 43602-544-05 | Ascent Pharmaceuticals | 6 October 2022 |
| 30 tablet in 1 bottle | 43602-544-30 | Ascent Pharmaceuticals | 6 October 2022 |
| 90 tablet in 1 bottle | 43602-544-90 | Ascent Pharmaceuticals | 6 October 2022 |
| 30 tablet, film coated in 1 bottle | 69306-266-30 | Doc Rx | 30 August 2022 |
| 60 tablet, film coated in 1 bottle | 69306-266-60 | Doc Rx | 1 August 2026 |
| 90 tablet, film coated in 1 bottle | 69306-266-90 | Doc Rx | 1 August 2026 |
| 90 tablet in 1 bottle | 49884-366-09 | Par Health | 22 March 2024 |
| 30 tablet, film coated in 1 bottle | 80425-0422-1 | Advanced Rx of Tennessee | 16 July 2024 |
| 60 tablet, film coated in 1 bottle | 80425-0422-2 | Advanced Rx of Tennessee | 16 July 2024 |
| 90 tablet, film coated in 1 bottle | 80425-0422-3 | Advanced Rx of Tennessee | 16 July 2024 |
| 30 tablet in 1 bottle | 80425-0483-1 | Advanced Rx of Tennessee | 22 March 2024 |
| 60 tablet in 1 bottle | 80425-0483-2 | Advanced Rx of Tennessee | 22 March 2024 |
| 90 tablet in 1 bottle | 80425-0483-3 | Advanced Rx of Tennessee | 22 March 2024 |
| 30 tablet in 1 bottle | 80425-0587-1 | Advanced Rx of Tennessee | 18 June 2026 |
| 60 tablet in 1 bottle | 80425-0587-2 | Advanced Rx of Tennessee | 18 June 2026 |
| 90 tablet in 1 bottle | 80425-0587-3 | Advanced Rx of Tennessee | 18 June 2026 |
| 30 tablet, film coated in 1 bottle | 85509-1010-3 | Phoenix RX | 21 July 2025 |
| 60 tablet, film coated in 1 bottle | 85509-1010-6 | Phoenix RX | 21 July 2025 |
| 90 tablet, film coated in 1 bottle | 85509-1010-9 | Phoenix RX | 21 July 2025 |
| 30 tablet in 1 bottle | 85509-1315-3 | Phoenix RX | 29 September 2025 |
| 60 tablet in 1 bottle | 85509-1315-6 | Phoenix RX | 29 September 2025 |
| 90 tablet in 1 bottle | 85509-1315-9 | Phoenix RX | 29 September 2025 |
| 30 tablet, film coated in 1 bottle | 85509-1626-3 | Phoenix RX | 7 April 2026 |
| 60 tablet, film coated in 1 bottle | 85509-1626-6 | Phoenix RX | 7 April 2026 |
| 90 tablet, film coated in 1 bottle | 85509-1626-9 | Phoenix RX | 7 April 2026 |
| 90 tablet, film coated in 1 bottle | 72189-641-90 | Direct_Rx | 18 September 2025 |
| 90 tablet in 1 bottle | 72189-667-90 | Direct_Rx | 22 June 2026 |
| 30 tablet in 1 bottle | 80425-0384-1 | Advanced Rx Pharmacy of Tennessee | 23 April 2024 |
| 60 tablet in 1 bottle | 80425-0384-2 | Advanced Rx Pharmacy of Tennessee | 23 April 2024 |
| 90 tablet in 1 bottle | 80425-0384-3 | Advanced Rx Pharmacy of Tennessee | 23 April 2024 |
| 100 tablet, film coated in 1 bottle | 76420-891-01 | Asclemed | 2 January 2025 |
| 500 tablet, film coated in 1 bottle | 76420-891-05 | Asclemed | 2 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 April 2011 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Famotidine and Ibuprofen is a fixed-dose combination of a histamine-2 receptor antagonist and a nonsteroidal anti-inflammatory drug. It is available as tablets for oral use. MedsAcross supplies Famotidine and Ibuprofen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Famotidine and IbuprofenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ibuprofen and famotidine prescribing information (Ascend Laboratories) · U.S. National Library of Medicine, DailyMed
Need Famotidine and Ibuprofen 26.6 mg/800 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.